BLLN
BillionToOne, Inc. Class A Common StockNASDAQHEALTHCAREDIAGNOSTICS & RESEARCH
Key Statistics
Market Cap
$3.93B
P/E Ratio
610.71
EPS
$0.14
Beta
—
52W High
$138.70
52W Low
$61.96
50-Day MA
$79.28
200-Day MA
$89.16
Dividend Yield
—
Profit Margin
0.96%
Forward P/E
—
PEG Ratio
—
About BillionToOne, Inc. Class A Common Stock
BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company is headquartered in Menlo Park, California.
Fundamentals
| Revenue (TTM) | $305.11M |
| Gross Profit (TTM) | $208.46M |
| EBITDA | $22.93M |
| Operating Margin | 10.80% |
| Return on Equity | 2.30% |
| Return on Assets | 2.14% |
| Revenue/Share (TTM) | $19.22 |
| Book Value | $10.48 |
| Price-to-Book | 7.56 |
| Price-to-Sales (TTM) | 12.88 |
| EV/Revenue | 10.62 |
| EV/EBITDA | 164.03 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 113.10% |
| Shares Outstanding | $41.41M |
| Float | $23.14M |
| % Insiders | 46.76% |
| % Institutions | 32.39% |
Analyst Ratings
Consensus ($116.71 target)
2
Strong Buy4
Buy2
HoldData last updated: 4/7/2026